Arbutus Biopharma Corporation ABUS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on the most recent quarter.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's quick ratio?
- Arbutus Biopharma Corporation (ABUS) reported quick ratio of 54.3× in Q1 2026.
- How has Arbutus Biopharma Corporation's quick ratio changed year-over-year?
- Arbutus Biopharma Corporation's quick ratio increased by 802.7% year-over-year, from 6× to 54.3×.
- What is the long-term trend for Arbutus Biopharma Corporation's quick ratio?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's quick ratio has grown at a 3.3% compound annual growth rate (CAGR), from 13.4× to 15.7×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.